StonvexLoading…
StonvexStonvexStonvexCore line items from GEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $446.56M | $1.63B | $1.19B | $775.66M |
Operating Income | $76.61M | $258.19M | $168.28M | $89.69M |
Net Income | $6.80M | $-440.40M | $-460.27M | $-469.48M |
EPS (Diluted) | $-0.06 | $-4.19 | $-4.23 | $-4.19 |
Total Assets | $4.84B | $4.86B | $4.87B | $4.84B |
Total Liabilities | $4.30B | $4.15B | $4.16B | $4.12B |
Cash & Equivalents | $4.21M | $6.44M | $4.92M | $4.45M |
Free Cash Flow OCF − CapEx | $55.68M | $65.94M | $-21.06M | $-64.35M |
Shares Outstanding | 122.46M | 122.46M | 122.46M | 122.46M |